Y‑incision versus standard aortic root enlargement for people with a small aortic annulus
Official title: Comparative Analysis of Standard Surgical Techniques vs. "Y Incision" Technique for Aortic Root Enlargement in Patients With Small Aortic Annulus Undergoing Aortic Valve Replacement: A Randomized Open-Label Controlled Trial (CRYSTAL Trial - Comparative Research of Y-Incision vs. Standard Techniques for Aortic Root EnLargement)
Run by Rambam Health Care Campus · NCT07368322 · Data updated 2026-11-12
This compares the Y‑incision versus standard surgical enlargement to see if surgeons can implant larger valves and reduce patient‑prosthesis mismatch in adults needing aortic valve replacement who have a small aortic annulus.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 90 (estimated) |
| Sponsor | Rambam Health Care Campus Academic / other |
| Locations | 1 site (Haifa) |
| Status | Recruiting |
| Started | January 4, 2026 |
| Main results expected | January 2028 |
| Study ends | January 2028 |
| Registry record updated | January 26, 2026 |
| Trial ID | NCT07368322 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–80 with aortic valve disease requiring AVR who have a small aortic annulus likely to cause moderate or severe patient‑prosthesis mismatch and who are judged suitable for surgery by the heart team are ideal candidates.
✕Probably not a fit
Patients without a small annulus where conventional AVR will not cause mismatch, those with prior cardiac surgery, active endocarditis, or severe additional valvular disease requiring other procedures are unlikely to benefit from this comparison.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study enrolls adults with severe aortic valve disease and a small aortic annulus who are candidates for surgical aortic valve replacement. Participants receive either the Y‑incision aortic root enlargement technique or a standard enlargement method during AVR, with operative details and valve sizes recorded. Key outcomes include perioperative safety, implanted prosthesis size, echocardiographic hemodynamic measures, rates of patient‑prosthesis mismatch, and functional capacity over follow‑up. The outcomes in the two groups are compared to determine whether the Y‑incision provides better hemodynamics and clinical results than standard techniques.
Why it matters
Potential benefit: If successful, the Y‑incision could allow implantation of larger prosthetic valves, reduce patient‑prosthesis mismatch, and improve hemodynamics and long‑term outcomes.
How similar studies have gone: Early case series and reports of the Y‑incision technique have shown promising ability to accommodate larger valves, but there are no large comparative or randomized trials definitively proving its safety and long‑term benefits.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged 18-80 years. * Patients must have signed and dated an ICF in accordance with regulatory and institutional guidelines before any protocol-related procedures and must be willing and able to comply with scheduled visits. * Diagnosed with aortic valve disease requiring aortic valve replacement. * Patients with small aortic annulus relative to body size where conventional AVR result in moderate or severe PPM (defined as cases where the largest prosthesis that can be implanted in the native annulus would provide a predicted iEOA ≤0.85 cm²/m² for BMI \<30, or ≤0.70 cm²/m² for BMI ≥30), based on manufacturer specifications and patient BSA). * Suitable candidates for surgery as determined by the heart team. Exclusion Criteria: 1. Patients for whom conventional AVR without root enlargement is not expected to result in patient-prosthesis mismatch. 2. Prior cardiac surgery. 3. Severe concomitant valvular disease requiring additional procedures. 4. Active endocarditis. 5. Severe chronic lung disease 6. Pre-existing lower limb deficits or any other medical comorbidities that interfere significantly with gait or the ability to perform exercise testing on a bicycle ergometer 7. Severe left ventricular dysfunction (LVEF \< 30%). 8. Contraindications to surgery. 9. Concurrent active treatment in another clinical trial
Where it's running
-
Rambam Health Care Campus
Haifa, Israel Recruiting
Study contacts
- Study coordinator: Nadav Willner, MD
- Email: n_willner@rmc.gov.il
- Phone: +972-50-8845456
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Modified procedure for enlarging the aortic root in patients with small aortic annulus
This study is testing a new way to enlarge the aortic root in people aged 50-70 with severe aortic stenosis and a small aortic annulus to see if it works better than the standard valve replacement method.
-
Hydra THV Transfemoral Valve Implantation in Severe Aortic Stenosis
This registry tests how safely and effectively the Hydra THV works when implanted through the femoral artery in adults with severe symptomatic aortic stenosis.
-
Noninvasive ECG Monitoring to Support Early Discharge After TAVI for Conduction Disorders
A noninvasive ECG monitoring approach is tested to see if it safely allows patients with conduction issues after TAVI to go home earlier.
-
FAPI-PET imaging to see heart tissue changes after TAVI for aortic stenosis
Using FAPI-PET scans, doctors will see if heart scarring and function improve after TAVI in people with severe aortic stenosis compared with those treated with medication alone.
-
Registry for patients with severe aortic valve stenosis undergoing TAVR with Myval valve
This study is testing how often heart rhythm problems happen and if patients need a pacemaker after getting a new heart valve through TAVR using the Myval valve.
-
Comparing heart valve prostheses for treating aortic stenosis
This study is testing how well different types of heart valve replacements work for people with severe aortic stenosis, especially those with smaller heart openings.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.